1-ethyl-4-(4-iodophenyl)benzene | CAS:17078-76-1

We serve 1-ethyl-4-(4-iodophenyl)benzene CAS:17078-76-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
1-ethyl-4-(4-iodophenyl)benzene

Chemical Name:  1-ethyl-4-(4-iodophenyl)benzene
CAS.NO: 17078-76-1
Synonyms:4-Aethyl-4'-iod-biphenyl
4-ethyl-4'-iodobiphenyl
1,1'-Biphenyl,4-ethyl-4'-iodo
4'-Iod-4-aethyldiphenyl
4-Iodo-4'-ethylbiphenyl
 
Molecular Formula: C14H13I
Molecular Weight: 308.15700
 
Physical and Chemical Properties:
Density: 1.5±0.1 g/cm3
Boiling point: 347.4±31.0 °C at 760 mmHg
Melting point: /
Flash point:157.5±13.9 °C
Refractive index: 1.617
 
Specification:
Appearance:White or off-white solid
Purity:>99.5%
 
Packing:20 kg/drum, can also be packaged according to customer requirements
Storage: Keep away from sources of ignition. Store in a cool, dry place. Keep container closed when not in use. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application:Applicationd as liquid crystal intermediate.



Contact us for information like 1-ethyl-4-(4-iodophenyl)benzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Iodo-4′-ethylbiphenyl physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-ethyl-4-(4-iodophenyl)benzene Use and application,4-Aethyl-4′-iod-biphenyl technical grade,usp/ep/jp grade.


Related News: Prime Minister Scott Morrison said Saturday that all travelers from mainland China allowed into Australia had to be quarantined for 14 days.4-Nitro-2,3-lutidine-N-oxide manufacturer Higher-risk MDS is a disease with significant unmet need, and we are pleased to be able to support healthcare professionals seeking access to rigosertib, ahead of its commercial launch,” said Mark Corbett, EVP, Inceptua Medicines Access.2,4-Difluoronitrobenzene supplier Higher-risk MDS is a disease with significant unmet need, and we are pleased to be able to support healthcare professionals seeking access to rigosertib, ahead of its commercial launch,” said Mark Corbett, EVP, Inceptua Medicines Access.4-Methylthiazole-5-carboxaldehyde vendor The market for pharmaceutical intermediates is vast and is expected to usher in new growth. Compared with the pesticide intermediate business, the market space for pharmaceutical intermediates is larger and will be the focus of the company’s future development.Targets within the tumor microenvironment may include both plasma membrane proteins as well as proteins typically secreted into the extracellular space.